作者: Alex G. Ortega-Loayza , Victoria P. Werth
DOI: 10.1007/978-3-662-45698-9_49
关键词: Sulfone 、 Dapsone 、 Bullous pemphigoid 、 Epidermolysis bullosa acquisita 、 Bullous disorders 、 Medicine 、 Dermatitis herpetiformis 、 Leprosy 、 Fda approval 、 Dermatology
摘要: Dapsone, a sulfone, was synthesized in the early twentieth century and has held longtime FDA approval to treat dermatitis herpetiformis leprosy. However, unlabeled uses of dapsone have become prevalent among dermatologist, especially autoimmune bullous diseases (AIBD).